|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Alexza Pharmaceuticals, Inc. (ALXA) Reports 2012 Third Quarter Financial Results and Provides Business Update
11/7/2012 9:53:22 AM
MOUNTAIN VIEW, Calif., Nov. 6, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (ALXA) today reported financial results for the fiscal quarter ended September 30, 2012 and provided a business update. The net loss for the quarters ended September 30, 2012 and 2011, as reported in accordance with accounting principles generally accepted in the United States (GAAP), were $6.9 million and $13.4 million, respectively. The net loss for the nine-month periods ended September 30, 2012 and 2011 were $17.7 million and $30.8 million, respectively. At September 30, 2012, Alexza had consolidated cash, cash equivalents, marketable securities and restricted cash of $32.0 million.
|
|
|
|
|
|
|
|
|
|
|